AI Stock Finder
Loading...
Skip to main content
Sign in Sign up
Model output · Signal date Oct. 15, 2026

Daily Signals

2696 companies scored · 2026-10-15 run in progress: 5121 of ~5380 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Create a free account Unlock all ratings
Signal date 2026-10-15 Cut-offs from the 2026-10-15 run
Companies scored 2696 IC ≥ 0 · market cap ≥ $100M
Median forecast +2.60% Total · 90D
Long–short spread +5.95% Strong Buy minus Strong Sell, mean
Median IC 0.28 Spearman · 90D
Rating changes ▲ 429 ▼ 601 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

-1.4% 0 +7.7%
Signals · All

304 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 LLYELI LILLY & Co Life Sciences 0.23 $1.1T Unlock rating and forecasts
2 JNJJOHNSON & JOHNSON Life Sciences 0.39 $611.9B Unlock rating and forecasts
3 ABBVAbbVie Inc. Life Sciences 0.01 $500.9B Unlock rating and forecasts
4 MRKMerck & Co., Inc. Life Sciences 0.21 $363.6B Unlock rating and forecasts
5 AZNASTRAZENECA PLC Life Sciences 0.06 $251.1B Unlock rating and forecasts
6 AMGNAMGEN INC Life Sciences 0.04 $230.4B Unlock rating and forecasts
7 GILDGILEAD SCIENCES, INC. Life Sciences 0.06 $190.4B Unlock rating and forecasts
8 ABTABBOTT LABORATORIES Life Sciences 0.11 $179.0B Unlock rating and forecasts
9 NVONOVO NORDISK A S Life Sciences 0.02 $169.4B Unlock rating and forecasts
10 PFEPFIZER INC Life Sciences 0.25 $166.5B Unlock rating and forecasts
11 BMYBRISTOL MYERS SQUIBB CO Life Sciences 0.43 $121.1B Unlock rating and forecasts
12 SNYSanofi Life Sciences 0.17 $98.0B Unlock rating and forecasts
13 GSKGSK plc Life Sciences 0.04 $96.6B Unlock rating and forecasts
14 MRNAModerna, Inc. Life Sciences 0.64 $90.3B Unlock rating and forecasts
15 REGNREGENERON PHARMACEUTICALS, INC. Life Sciences 0.23 $80.5B Unlock rating and forecasts
16 ARGXARGENX SE Life Sciences 0.29 $50.6B Unlock rating and forecasts
17 IDXXIDEXX LABORATORIES INC /DE Life Sciences 0.42 $41.7B Unlock rating and forecasts
18 RVMDRevolution Medicines, Inc. Life Sciences 0.40 $41.5B Unlock rating and forecasts
19 ONCBeOne Medicines Ltd. Life Sciences 0.19 $40.0B Unlock rating and forecasts
20 BIIBBIOGEN INC. Life Sciences 0.41 $34.2B Unlock rating and forecasts
21 RPRXRoyalty Pharma plc Life Sciences 0.59 $33.9B Neutral +0.84% +2.96% ·
22 ZTSZoetis Inc. Life Sciences 0.28 $31.1B Unlock rating and forecasts
23 ALNYALNYLAM PHARMACEUTICALS, INC. Life Sciences 0.57 $30.0B Neutral +0.86% +2.52% ▲ 2
24 ZLABZai Lab Ltd Life Sciences 0.42 $25.3B Neutral +1.32% +2.13% ·
25 ROIVRoivant Sciences Ltd. Life Sciences 0.28 $24.3B Unlock rating and forecasts
26 GMABGENMAB A/S Life Sciences 0.02 $23.7B Neutral +0.98% +2.92% ·
27 UTHRUNITED THERAPEUTICS Corp Life Sciences 0.22 $23.2B Unlock rating and forecasts
28 BNTXBioNTech SE Life Sciences 0.02 $22.4B Unlock rating and forecasts
29 INSMINSMED Inc Life Sciences 0.42 $21.4B Neutral +0.77% +2.36% ▲ 1
30 VTRSViatris Inc Life Sciences 0.36 $20.0B Neutral +0.76% +2.44% ·
31 ASNDAscendis Pharma A/S Life Sciences 0.00 $15.0B Unlock rating and forecasts
32 NBIXNEUROCRINE BIOSCIENCES INC Life Sciences 0.10 $13.8B Unlock rating and forecasts
33 JAZZJazz Pharmaceuticals plc Life Sciences 0.40 $13.6B Unlock rating and forecasts
34 HALOHALOZYME THERAPEUTICS, INC. Life Sciences 0.30 $13.3B Neutral +0.87% +2.58% ·
35 BBIOBridgeBio Pharma, Inc. Life Sciences 0.07 $12.7B Neutral +0.91% +2.83% ·
36 CORTCORCEPT THERAPEUTICS INC Life Sciences 0.55 $12.6B Unlock rating and forecasts
37 SMMTSummit Therapeutics Inc. Life Sciences 0.31 $12.1B Unlock rating and forecasts
38 TECHBIO-TECHNE Corp Life Sciences 0.31 $11.4B Unlock rating and forecasts
39 ELANElanco Animal Health Inc Life Sciences 0.36 $11.3B Neutral +0.55% +2.05% ▼ 1
40 BMRNBIOMARIN PHARMACEUTICAL INC Life Sciences 0.32 $10.7B Unlock rating and forecasts
41 IBRXImmunityBio, Inc. Life Sciences 0.14 $10.5B Unlock rating and forecasts
42 RGENREPLIGEN CORP Life Sciences 0.62 $10.1B Neutral +1.00% +3.08% ▼ 1
43 QGENQIAGEN N.V. Life Sciences 0.17 $9.9B Neutral +0.71% +2.24% ▲ 1
44 KRYSKrystal Biotech, Inc. Life Sciences 0.18 $9.8B Neutral +0.56% +1.98% ·
45 TWSTTwist Bioscience Corp Life Sciences 0.59 $9.3B Unlock rating and forecasts
46 CYTKCYTOKINETICS INC Life Sciences 0.44 $8.8B Unlock rating and forecasts
47 AXSMAxsome Therapeutics, Inc. Life Sciences 0.00 $8.5B Unlock rating and forecasts
48 ARWRARROWHEAD PHARMACEUTICALS, INC. Life Sciences 0.03 $8.2B Unlock rating and forecasts
49 IONSIONIS PHARMACEUTICALS INC Life Sciences 0.39 $7.1B Unlock rating and forecasts
50 SYRESpyre Therapeutics, Inc. Life Sciences 0.45 $6.9B Unlock rating and forecasts
1–50 of 304 Previous Next
Breadth

By sector

Median 90D forecast per sector. Click to filter.

Finance or Crypto Assets44 +5.2% Life Sciences304 +4.2% Technology369 +3.1% Manufacturing430 +2.6% Trade & Services351 +2.5% Energy & Transportation288 +2.3% Industrial Applications and Services285 +2.2% Finance389 +2.2% Real Estate & Construction225 +1.8% Crypto Assets11 -0.9%
Since the previous run

Rating changes

▲ 429▼ 601
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.

Intratio is a company specialized in predictive and optimization algorithms. We forecast all US-listed stock prices. We provide our clients with the most advanced tools to build optimal stock portfolios.

Quantitative research output, not investment advice.

Connect
English
Français
Español
العربية
简体中文
Deutsch
日本語
한국어
Português
Русский
Türkçe
हिन्दी
Bahasa Indonesia
Italiano

2018–2026 © AI Stock Finder. All Rights Reserved.

  • Visa
  • Mastercard
  • American Express
  • PayPal